Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

6.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

579
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
579
Clinical Trials01:16

Clinical Trials

11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

170
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
170
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

228
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
228

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breast cancer survival rates and determinants in Ethiopia: a systematic review and meta-analysis of longitudinal studies.

BMC cancer·2025
Same author

Measuring Adverse Event Burden in Myasthenia Gravis: Retrospective Validation of the Adverse Event Unit With Randomized Trial of Thymectomy in Myasthenia Gravis Data.

Muscle & nerve·2025
Same author

Epidemiology of Ciguatoxin Poisoning Outbreaks in the United States Between 2001 and 2021.

Foodborne pathogens and disease·2024
Same author

Outcomes of Referrals in Pediatric Patients With Peripheral Lymphadenopathy.

Journal of pediatric hematology/oncology·2024
Same author

Does Asthma Increase the Odds of Suicidal Thoughts, Plans, and Attempts?

Cureus·2024
Same author

Design, analysis, and interpretation of treatment response heterogeneity in personalized nutrition and obesity treatment research.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2023
Same journal

PI3K/Akt pathway in ischemic stroke: A central regulator of neuronal survival and repair.

Experimental neurology·2026
Same journal

Hepatokines and stellakines in liver and neurological diseases: The liver-brain axis.

Experimental neurology·2026
Same journal

Structural dynamics of α-Synuclein: Multi-scale imaging insights into pathological progression across Synucleinopathies.

Experimental neurology·2026
Same journal

Retraction notice to 'Mitochondrial ferritin upregulation reduced oxidative stress and blood-brain-barrier disruption by maintaining cellular iron homeostasis in a neonatal rat model of germinal matrix hemorrhage' [Experimental Neurology 374 (2024) 114703].

Experimental neurology·2026
Same journal

Sivelestat sodium alleviates blood-brain barrier dysfunction after traumatic brain injury by reduction of NETs formation.

Experimental neurology·2026
Same journal

Corrigendum to "Primary and Immortalized Microglia Exhibit Divergent Responses to Hemoglobin" [Experimental Neurology 403 (2026) 115838].

Experimental neurology·2026
See all related articles

Related Experiment Video

Updated: Apr 16, 2026

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

54.8K

Statistical considerations for preclinical studies.

Inmaculada B Aban1, Brandon George1

  • 1Department of Biostatistics, University of Alabama at Birmingham, AL, USA.

Experimental Neurology
|March 1, 2015
PubMed
Summary
This summary is machine-generated.

Enhancing preclinical study rigor is crucial for reliable drug development. This paper details statistical methods in design, sample size, and analysis to improve preclinical research quality and integrity.

Keywords:
False positiveMissing dataMultiple outcomesPowerPreclinical studiesRandomizationSample size

More Related Videos

Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

4.1K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.5K

Related Experiment Videos

Last Updated: Apr 16, 2026

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

54.8K
Lipidomics and Transcriptomics in Neurological Diseases
09:58

Lipidomics and Transcriptomics in Neurological Diseases

Published on: March 18, 2022

4.1K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.5K

Area of Science:

  • Pharmacology and Toxicology
  • Biostatistics
  • Drug Development

Background:

  • Preclinical studies are foundational for drug development, guiding decisions for human clinical trials.
  • A significant number of preclinical studies currently lack sufficient rigor in conduct and reporting.
  • Ensuring scientific integrity in early-stage research is paramount.

Purpose of the Study:

  • To highlight the importance of statistical rigor in preclinical research.
  • To provide guidance on improving the quality of preclinical studies through statistical methods.
  • To address the issue of inadequate rigor in preclinical study design, conduct, and analysis.

Main Methods:

  • Discussion of statistical design principles for preclinical studies.
  • Explanation of methods for determining appropriate sample sizes.
  • Overview of robust statistical analysis techniques applicable to preclinical data.

Main Results:

  • Preclinical studies require meticulous planning, execution, and analysis for valid results.
  • Statistical methodologies are key to enhancing the rigor and reproducibility of preclinical research.
  • Improved statistical practices can increase confidence in data used for clinical trial progression.

Conclusions:

  • Implementing sound statistical practices is essential for maintaining scientific integrity in preclinical research.
  • Addressing the lack of rigor in preclinical studies will improve the reliability of drug development pipelines.
  • This paper advocates for the adoption of advanced statistical methods to elevate preclinical study quality.